{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "FETAL MONITORING IN LABOUR"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MEHT-21011"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Obstetricians and midwives"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "14 July 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "13 July 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Fetal, monitoring"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "To support a standardised approach to clinical decision making regarding the indication, interpretation and care planning when fetal monitoring is required based on the most current evidence and fetal physiology."
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women and Children's Directorate"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Kat Reeves, Fetal Surveillance Midwife"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Guideline Steering Group"
                    },
                    {
                        "text": "16 February 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Mr Mandeep Singh, Group Clinical Lead for Women's Services"
                    },
                    {
                        "text": "16 February 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Control Group"
                    },
                    {
                        "text": "13 July 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "July 2021"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Vidya Thakur"
                    },
                    {
                        "text": "Consultant Obstetrician and Clinical Lead for Labour Ward"
                    },
                    {
                        "text": "21 June 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Committee if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Maternity and Gynaecology Practice Steering Group (Chair's Action)"
                    },
                    {
                        "text": "29 June 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "OG209 Antenatal CTG monitoring using Dawes Redman guideline 04291 Induction of Labour 04264 Emergency lower segment caesarean section 06030 Management of vaginal birth after caesarean section 06034 Reduced fetal movement"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Kat Reeves"
                    },
                    {
                        "text": "New guideline which replaces the following at Broomfield Hospital: 04265 Fetal heart rate monitoring in pregnancy guideline. This document has been adapted from Basildon Hospital's guideline written by Caron Ingram, Fetal Surveillance Midwife, Neerja Gupta Obstetric Consultant, Abisola Adeleye Obstetric Consultant, Edwin Chandraharan Obstetric Consultant. Change from NICE CTG classification to Physiological CTG Interpretation 2018: https://physiological-ctg.com/guideline.html"
                    },
                    {
                        "text": "14 July 2021"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Introduction ................................................................................................................. 5  Scope ........................................................................................................................... 5  Definitions ................................................................................................................... 5  Role and Responsibilities within the Trust............................................................... 6  Fetal Monitoring .......................................................................................................... 6  Fetal monitoring during insertion of an epidural analgesia .................................... 7  Storage of CTG traces ................................................................................................ 7  Systematic Assessment ............................................................................................. 8  Fresh Eyes Review ..................................................................................................... 9  The use of the Central Monitor (The \u201cNeighbourhood Watch\u201d) ............................. 9  CTG classification .................................................................................................... 10  Acute Tocolysis for intrauterine fetal resuscitation .............................................. 13  Normal CTG in labour has the following features: ................................................ 14"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Concerning features observed on the CTG in labour: .......................................... 14  Evidence of an evolving or subacute hypoxia on the CTG trace during labour . 15  Adjunctive Tests of Fetal Well-being ...................................................................... 15  Management of acute hypoxia................................................................................. 16  Management of Gradually Evolving Hypoxic Stress ............................................. 17"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Chorioamnionitis ...................................................................................................... 17  Meconium Staining of Amniotic Fluid (MSAF) ....................................................... 19  Intrapartum monitoring of a preterm fetus ............................................................. 19  General Principles .................................................................................................... 20  Cord pH Measurement ............................................................................................. 20  Combined continuous fetal monitoring with ST-Analysis (STAN) ....................... 22"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 35.0,
                "text": "Fresh Eyes Approach ............................................................................................... 24  Use of Oxytocin to augment labour ........................................................................ 25  Fetal heart rate monitoring during low risk labour ................................................ 25  Training Requirements ............................................................................................. 28  Dawes Redman Analysis \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u202628 30 Day assessment in the stand alone units\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026..28  Monitoring and Audit ................................................................................................ 34  Approval and Implementation ................................................................................. 34  Equality Impact Assessment ................................................................................... 34  References ................................................................................................................ 35  Bibliography .............................................................................................................. 35 Appendix 1: Checklist to exclude pre-existing hypoxia or injury ................................ 39 Appendix 2: Hourly CTG assessment/Fresh Eyes CTG sticker ................................... 40 Appendix 3: Fresh Eyes sticker for \u201cintelligent\u201d intermittent auscultation ................ 41 Appendix 4: CTG features of Chorioamnionitis ............................................................ 42 Appendix 5: List of indications for Continuous CTG Monitoring ................................ 43 Appendix 6: CTG classification to be used with STAN ................................................ 45 Appendix 7: Management Algorithm for the use of STAN ........................................... 46 Appendix 8: Dawes Redman Analysis ........................................................................... 46 Appendix 9: Preliminary Equality Analysis .................................................................. 49"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This  guideline  encompasses  intermittent  auscultation  and  continuous  electronic fetal monitoring, both of which aim to identify significant fetal hypoxia developing during labour. It is essential that clear, concise and consistent information is given to the woman prior to the commencement of fetal monitoring taking into account her wishes and obstetric history. This should be documented clearly in the notes, and should she express a preference not to be monitored using the recommended method, this should be escalated to the on call obstetric registrar as soon as possible to facilitate informed decision making. Discussion must include the risks of not being monitored."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "prefix": 2.1,
                "text": "Important information:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "text": "2.1.1 This guideline describes fetal monitoring using physiology-based CTG interpretation, which has been developed by the editorial board, in conjunction with 34 CTG experts in 14 countries, based on the experience gained from maternity units where a reduction in the emergency caesarean section rate and/or an improvement in perinatal outcomes were demonstrated after the implementation of physiology-based fetal monitoring. (Physiological CTG Interpretation 2018)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "text": "2.1.2 It is important to stress that fetal monitoring is only part of the overall clinical assessment of both mother and fetus, aimed mainly at the detection of fetal hypoxia. This guidance must be used within the context of the whole clinical picture, taking into account other non-hypoxic factors causing fetal injury. This is particularly important when events are evolving rapidly necessitating interventions irrespective of fetal monitoring."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "text": "2.1.3 This guidance is based on the evidence available at the time of creating this document, which are listed in the reference section of this document. We recognise that it is impossible for any guideline to cover every clinical scenario, hence it is important for clinicians using this guidance to apply it in accordance with their clinical expertise and logic, and to seek a second opinion whenever required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            }
        },
        {
            "type": "table",
            "sequence_num": 21,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "CTG"
                    },
                    {
                        "text": "Cardiotocograph"
                    },
                    {
                        "text": "CDS"
                    },
                    {
                        "text": "Central Delivery Suite Ward"
                    },
                    {
                        "text": "ECG"
                    },
                    {
                        "text": "Electro cardio graph"
                    },
                    {
                        "text": "EFM"
                    },
                    {
                        "text": "Electronic fetal monitoring"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 22,
            "data": {
                "num_rows": 14,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "FBS"
                    },
                    {
                        "text": "Fetal blood sample"
                    },
                    {
                        "text": "FHR"
                    },
                    {
                        "text": "Fetal heart rate"
                    },
                    {
                        "text": "FIGO"
                    },
                    {
                        "text": "International Federation of Gynaecology and Obstetrics"
                    },
                    {
                        "text": "FSE"
                    },
                    {
                        "text": "Fetal scalp electrode"
                    },
                    {
                        "text": "GA"
                    },
                    {
                        "text": "General anaesthetic"
                    },
                    {
                        "text": "GDM"
                    },
                    {
                        "text": "Gestational diabetes mellitus"
                    },
                    {
                        "text": "IUGR"
                    },
                    {
                        "text": "Intra uterine growth restriction"
                    },
                    {
                        "text": "LW"
                    },
                    {
                        "text": "Labour ward"
                    },
                    {
                        "text": "MLBU"
                    },
                    {
                        "text": "Midwife Led Birth Unit"
                    },
                    {
                        "text": "MAS"
                    },
                    {
                        "text": "Meconium aspiration syndrome"
                    },
                    {
                        "text": "MDT"
                    },
                    {
                        "text": "Multidisciplinary team"
                    },
                    {
                        "text": "MSAF"
                    },
                    {
                        "text": "Meconium stained amniotic fluid"
                    },
                    {
                        "text": "STAN"
                    },
                    {
                        "text": "ST analysis"
                    },
                    {
                        "text": "VE"
                    },
                    {
                        "text": "Vaginal examination"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "The Clinical Director is responsible for the implementation of this guideline within the directorate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "The Obstetric Clinical Lead Consultant and Labour Ward Lead Consultant are responsible for ensuring the implementation of this guideline within the clinical setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "The Head of Midwifery, maternity matrons and maternity managers are responsible for ensuring maternity staff are aware of the guideline and implement it."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "The Fetal Surveillence Midwife and Practice Development team are responsible for ensuring all staff are trained and updated in fetal monitoring."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "All maternity staff are responsible for ensuring they are familiar with this guideline in relation to their practice and have the appropriate skills to implement this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Fetal monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "Initial assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "5.1.1 On admission in labour there should be a reassessment of risk factors and discussion identifying the most appropriate method of monitoring. Intermittent monitoring is recommended if labour is deemed to be \u201clow risk\u201d. (Please see Section 29 below: Fetal Monitoring in Low Risk Labour)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "Indications for Continuous Electronic Fetal Heart Rate Monitoring using the Cardiotocograph (CTG)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "5.2.1 Indications for continuous CTG monitoring that may be present at initial assessment or arise during labour. Any condition that increases the likelihood of fetal injury operating via hypoxic, inflammatory, metabolic or hypotensive pathways would"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "warrant continuous electronic fetal heart rate monitoring to avoid the potentiating effect of additional intrapartum hypoxic stress."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "5.2.2 Please see Appendix 5 List of Indications for Continuous CTG Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 1,
                "prefix": 5.3,
                "text": "Continuous electronic fetal heart rate monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "5.3.1 Prior to commencing CTG monitoring the fetal heart should be auscultated with a pinard stethoscope or a hand held Doppler. The following should be double checked at the time of commencement of CTG monitoring:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "Indication for CTG monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "Date and Time \u2013 Coordinators should ensure that date and time are accurate on CTG machines the day after changes in \u2018day-light saving' time (March & October)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "Paper Speed (1 cm/minute)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "The minimum data that should be recorded on the tracing include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "Woman's Name"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "Date of Birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "Hospital Number"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "Date and time"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "text": "Maternal pulse and temperature at the commencement of monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "text": "5.3.2 Intrapartum events should be documented contemporaneously in the medical records, including opinions requested from review at the central monitoring station. In paper CTG copies, it is good practice to document the events on the CTG trace as well."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Fetal monitoring during insertion of an epidural analgesia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The fetal heart must be monitored continuously throughout the procedure. If there is difficulty monitoring using an abdominal transducer, the application of a fetal scalp electrode (FSE) should be considered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "If at any time during the procedure the midwife is concerned about the fetal heart they should request the anaesthetist to stop the procedure and request senior midwifery and/or medical assistance. This is very important whilst monitoring twins during labour and a FSE should be considered to avoid erroneous monitoring of the same twin twice."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Storage of CTG traces"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "The FHR trace should be stored securely with the woman's medical records at the end of the monitoring process. CTGs printed on heat sensitive paper should be securely stored in an appropriate purpose made \u201cbrown\u201d envelope and secured in the records."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "All traces if connected to Huntleigh Central Monitoring should store electronically and can be reprinted from there (this will be applicable to Mid-Essex when Central monitoring is introduced)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Systematic assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "A systematic assessment of the trace should be made every hour by the case midwife or more frequently if there are concerns. Any deviations from the norm should be escalated to the CDS Co-ordinator and if appropriate, to the obstetric team on call. This assessment should be recorded in the medical notes, if available, CTG assessment tool sticker (appendix 2) should be used. If not available, please document in the following structure:"
            }
        },
        {
            "type": "table",
            "sequence_num": 56,
            "data": {
                "num_rows": 8,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "DR C BRAVADO mnemonic"
                    },
                    {
                        "text": "DR"
                    },
                    {
                        "text": "Define risk"
                    },
                    {
                        "text": "C"
                    },
                    {
                        "text": "Contractions"
                    },
                    {
                        "text": "BR"
                    },
                    {
                        "text": "Baseline rate"
                    },
                    {
                        "text": "A"
                    },
                    {
                        "text": "Accelerations"
                    },
                    {
                        "text": "VA"
                    },
                    {
                        "text": "Variability"
                    },
                    {
                        "text": "D"
                    },
                    {
                        "text": "Decelerations"
                    },
                    {
                        "text": "O"
                    },
                    {
                        "text": "Overall \u2013 Are the fetal central organs well oxygenated? (ie stable baseline FR and reassuring variability"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Regular and critical review of antenatal, medical or intrapartum risk factors is an essential part of CTG interpretation. Always compare the current CTG recording with the CTG at the beginning of labour / induction of labour or during the antenatal period to determine the changes in the baseline FHR, variability and cycling over time."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Fresh eyes review"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Every hour the midwife looking after the woman should seek a \u2018fresh eyes approach' from a colleague such as band 6 midwife, the co-ordinator/second band 7 or the obstetric Registrar or Consultant on call. If both coordinators are unavailable, fresh eyes should not be postponed and another senior band 6 midwife should do this with the midwife instead."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "If there are concerns with CTG or additional concerns by the case midwife (e.g. meconium, chorioamnionitis or intrapartum bleeding), the Fresh Eyes review should take place earlier than planned."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "Fresh eyes should involve assessing any changes in the baseline FHR (i.e. catecholamine surge or infection), evidence of continued central organ oxygenation (i.e. a stable baseline and reassuring variability), presence of cycling and onset of additional intrapartum risk factors (meconium, maternal pyrexia, epidural, oxytocin infusion) etc. Documentation of this should occur on CTG assessment tool (appendix 2) or using DRCBRAVADO pneumonic."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "On occasions when the case midwife and the \u201cfresh eyes\u201d reviewer disagree; a further review should be requested from the coordinator or middle grade/senior obstetrician. On the rare occasion when an agreement is still not met, any member of the team interpreting the CTG should have the opportunity to ask for a \u201cCTG huddle\u201d. This would involve the team (case midwife, senior midwife, registrar, the consultant and fetal surveillance midwife if available and any other persons requested) coming together to discuss the case in its entirety. The aim of this being that everyone has the opportunity to air their concerns, discuss the relevant pathophysiology and make a plan of care away from the woman. The woman should then be informed of the discussion and the recommended plan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "The use of the Central Monitor (The \u201cNeighbourhood Watch\u201d) (to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "text": "be applicable to Mid-Essex when central monitoring has been implemented)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The central monitor should be utilised to obtain second opinion whenever required. Although the labour ward co-ordinator and the most senior member of the obstetric team have an overall responsibility for the central monitor, it is important to note that if the labour ward is busy and the obstetric team and/or the labour ward co-ordinator is busy with emergencies, it may not be possible to review the central monitor."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Therefore, it is the responsibility of the case midwife in the room to carefully scrutinise the CTG trace and escalate whenever necessary, and it is the responsibility of all the midwives and obstetricians during the shift to carefully scrutinise the Central Monitor and to escalate their concerns. However, reviews and plans should always take place at the bedside of the woman to ensure holistic care, not just CTG interpretation in isolation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 1,
                "prefix": 10.3,
                "text": "Provision of safe intrapartum care by ensuring the highest standards of intrapartum fetal heart rate monitoring is everyone's responsibility."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "CTG classification"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "The multidisciplinary team (MDT) providing intrapartum care at Mid-Essex Maternity Unit uses the Physiological Interpretation of CTG guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "11.1.1 Please refer to https://physiological-ctg.com/guideline.html  for the Full Physiological CTG Guideline developed by 34 CTG experts from  countries in 2018, with the aim of individualisation of care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 1,
                "prefix": 11.2,
                "text": "Is the fetus fit to undertake the journey of labour?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "text": "11.2.1 This sticker/checklist should be used at the beginning of labour for women who require continuous CTG monitoring and prior to commencing induction of labour. This can be done after the first CTG before IOL is started or at the start of labour if spontaneous onset."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "text": "11.2.2 The \u201cFetal Monitoring Checklist\u201d (see appendix 1) should be used at the beginning of labour or before induction of labour for women requiring continuous monitoring to exclude pre-existing hypoxia, chorioamnionitis or other non-hypoxic injury, by asking the question \u201cIs the Fetus Fit for Labour\u201d?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "text": "11.2.3 If the fetus is deemed not fit to undertake the journey of labour based on the observed CTG changes, delivery should be accomplished without subjecting the fetus to further hypoxic stresses. Artificial rupture of membranes (ARM) should be avoided, and a \u201ccategory 2\u201d emergency caesarean section should be carried out. However, if the overall clinical situation requires an urgent delivery, then a \u201cCategory 1\u201d Caesarean section should be performed. Tocolytics should be administered if there are ongoing contractions. For a fetus with pre-existing hypoxia or injury, scientific studies have shown that even Braxton-Hicks contractions may cause neurological injury (Bower. S et al 1991). Therefore, even if there are 1 or 2 uterine contractions, tocolysis should be administered to reduce the likelihood of fetal neurological injury until delivery is accomplished."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "text": "11.2.4 Effective communication with the anaesthetists to avoid maternal hypotension during regional anaesthesia is crucial."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 1,
                "prefix": 11.3,
                "text": "How is the fetus?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "text": "11.3.1 Each time the CTG trace is assessed, clinicians should determine if the fetus is exposed to mechanical or hypoxic stress, and if there is evidence of effective compensation i.e. no evidence of central organ depression (Appendix 2) (Please refer to the Table 1 on page 13 to understand the different types of fetal hypoxia based on the observed CTG changes)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "11.3.2 The features observed on the CTG trace should be compared to the previous / earlier CTG traces of the same fetus to determine the rise in the baseline, changes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "in the variability, accelerations, decelerations and the presence or absence of cycling."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "11.3.3 In gradually evolving hypoxia with a catecholamine surge, or during subacute hypoxia, urgent action should be taken to stop the ongoing hypoxic stress to improve oxygenation of the fetus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "prefix": 25.0,
                "text": "11.3.4 Excessive baseline variability of >  bpm (i.e. saltatory or the \u201cZigZag\u201d pattern) should warrant an urgent action to relieve the hypoxic stress."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "text": "11.3.5 Rare CTG patterns such as typical, atypical (the \u201cPoole Shark Teeth\u201d) sinusoidal patterns should warrant an immediate delivery irrespective of the presence of decelerations. No action is necessary in a pseudo-sinusoidal pattern interspersed with accelerations and normal variability."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "11.3.6 Most decelerations in labour are variable (80-90%) \u2013 characterised by a quick onset and a rapid recovery (\u201cV\u201d shaped). These are believed to be mediated through the baro-receptors or peripheral chemoreceptors and are not associated with hypoxia or acidosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "The following additional parameters need to be considered whilst interpreting the CTG trace:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "Ensure that the baseline fetal heart rate is appropriate for the gestational age of the given fetus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "A baseline of > 150 bpm at 40 weeks should be considered as abnormal. Subclinical chorioamnionitis and chronic hypoxia need to be excluded."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "A baseline > 140 bpm at 41 weeks of gestation should be considered as abnormal. Subclinical chorioamnionitis and chronic hypoxia need to be excluded."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "prefix": 50.0,
                "text": "Presence of fetal heart rate cycling (active and quiescent phases) characterised by alternative periods of normal and reduced variability approximately once in every  minutes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "Presence of shallow decelerations with persistently reduced baseline heart rate variability with higher than expected baseline (chronic hypoxia)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "Presence of a pre-terminal trace (total loss of variability and reactivity)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Presence of a saltatory pattern or the \u201cZigZag\u201d Pattern (variability >25 beats /min) especially in association with oxytocin infusion or in second stage of labour with active pushing, often in association with recurrent atypical variable decelerations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "A significant (>10%) rise in the baseline fetal heart rate (even if it remains within the normal range) without preceding decelerations with or without absence of cycling suggestive of chorioamnionitis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "11.4.1 Always remember Individualise Care by comparing the observed features on the CTG trace with the previously observed fetus in the same fetus, and considering the wider clinical picture (Meconium staining of amniotic fluid, intrapartum bleeding, reduced fetal reserve, GDM, poor rate of progress of labour, maternal pyrexia, pre- eclampsia)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "The classification of hypoxia table showing the features of different types of hypoxia:"
            }
        },
        {
            "type": "image",
            "sequence_num": 95,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.004.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Acute tocolysis for intrauterine fetal resuscitation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Terbutaline 250 mcg should be administered subcutaneously in all clinical situations whereby:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "The observed CTG changes are secondary to increased frequency, duration or strength of uterine contractions, and persist even after stopping oxytocin infusion or removal of prostaglandins."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "Evidence of subacute hypoxic pattern and/or reduced baseline variability or the ZigZag Pattern when a spontaneous or operative vaginal birth is not imminent (i.e. vertex is > +2 station)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "Any condition where continuation of uterine contractions may lead to further fetal compromise (e.g. umbilical cord prolapse, chronic hypoxia or ongoing chorioamnionitis with co-existing hypoxic stress secondary to uterine contractions)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "In second stage of labour, the overall clinical situation should be considered, and fetal condition should be optimised by administering tocolysis in the presence of acute, subacute or a gradually evolving hypoxia, even if a decision is made for an operative delivery, unless a spontaneous or operative vaginal birth is imminent. Failure to administer tocolysis may lead to continuation of hypoxic stress leading to decompensation and poor outcome during the delay due to transfer to the operating theatre and administering effective anaesthesia prior to the operative delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "As hypoxic ischaemic encephalopathy (HIE) and the resultant cerebral palsy are irreversible, tocolysis can be used in an emergency to improve fetal oxygenation, with the agreement of the obstetric team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "When prostaglandin or oxytocin is prescribed, the obstetric team should prescribe terbutaline 250 micrograms s/c simultaneously so that the midwife can administer this if there is any evidence of uterine hyperstimulation, if the obstetric team is busy. The midwife must discuss with a senior obstetrician or co-ordinator prior to administering any terbutaline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "text": "If increased uterine activity continues despite the use of acute tocolysis, pathological causes of uterine myometrial irritability (concealed placental abruption or intrauterine or maternal infection irritating the myometrium) should be excluded."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 1,
                "text": "PLEASE NOTE: Terbutaline Sulfate can commonly cause Hypotension (BNF 2020)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Normal CTG in labour has the following features:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "text": "Good contact for > 80% of the recording (i.e. no loss of signal quality for prolonged periods of time), has no interference and has a good technical quality. The maximal period of stress is in the second stage of labour just prior to delivery and every effort should be made to have continuous, uninterrupted CTG monitoring in high risk labour."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Both FHR and contractions recorded clearly. If monitoring of the uterine contractions is not possible, reasonable effort must be made to mark the trace to denote their occurrence."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "text": "Reassuring features in accordance with guidelines above (Table 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "Interpretation of the CTG should take into consideration the stage of labour, progress in labour, maternal and fetal condition, and prior or additional risk factors present."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "text": "If repeated \u201ctrue\u201d accelerations are present, the trace should be regarded as normal. However, if the baseline FHR is reduced, then the CTG trace should be scrutinised to exclude overshoots of shallow or variable decelerations, which may create a false impression of accelerations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "text": "True early uniform decelerations are rare and benign, and therefore they are not significant."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Concerning features observed on the CTG in labour:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "(Based on \u201cHourly CTG assessment tool\u201d (please see appendix 2) or if there is any sentinel hypoxic event such as presence of meconium or fresh intrapartum bleeding)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "text": "Midwife should escalate concerns to the Midwife in charge or the obstetrician."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "text": "Consider change of maternal position to relieve aortocaval compression (left lateral)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "Take maternal pulse and BP (and temperature, if tachycardic fetal heart rate or if the baseline FHR > 10% of the original)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "If there is evidence of epidural induced hypotension, 500 mls of Hartmann's solution (or normal saline 0.9% if no Hartmann's available) should be rapidly infused, (unless the woman is known to have cardiac disease or severe pre- eclampsia) and the anaesthetist should be requested to attend."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "text": "If oxytocin augmentation is in progress, this should be reviewed by the obstetric team. The infusion should be continued to achieve adequate uterine activity in the presence of a stable baseline FHR, a reassuring variability with presence of cycling and with no evidence of a fetal catecholamine surge."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "text": "Document the measures taken and plan of care in the medical notes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "Ensure \u2018chronic hypoxia', absence of cycling, sinusoidal patterns and pre- terminal traces are classified appropriately"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "A tachycardia of 160\u2013180 bpm, where accelerations are present and no other adverse features appear, should be viewed with caution and specific causes (maternal dehydration, infection and a gradually evolving hypoxia, fetal cardiac rhythm abnormalities) should be excluded."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "text": "However, an increase in the baseline heart rate, even within the normal range, with preceding decelerations or loss of baseline variability should raise concern. If there is absence of cycling, and if intrauterine resuscitation is not possible or appropriate, an urgent delivery should be accomplished."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Evidence of an evolving or subacute hypoxia on the CTG trace"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 1,
                "text": "during labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Follow the measures as outlined above, and in addition:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "text": "Abdominal examination for tenderness"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "Consider VE (for head on perineum, cord prolapse, detection of full dilatation, intrapartum haemorrhage, meconium)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "text": "Stop oxytocin infusion and inform Registrar and Midwife in Charge. Repeatedly turning oxytocin off can lead to failed augmentation, but there should be a full assessment by the obstetrician before recommencing augmentation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "In cases of hyperstimulation (contractions > 5:10 or uterine hypertonus with CTG abnormalities), consider 0.25 mg Terbutaline SC (this may also be required if there is a delay in transfer to theatre, or if oxytocin has been given before delivery of an undiagnosed second twin)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Adjunctive tests of fetal well-being"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "The obstetric team may consider additional tests of fetal wellbeing such as fetal scalp stimulation or fetal ECG. According to current scientific evidence based on Cochrane Systematic Reviews (2006, 2013, 2017 and 2019), the use of scalp blood sampling (FBS) does not improve long term outcomes and does not reduce operative delivery rate. NICE (2014) has concluded that it may in fact increase caesarean section rate and instrumental vaginal births. A recent UK prospective multicentre study has concluded that FBS does not improve perinatal outcomes and may increase operative interventions by 60% (Al Wattar et al 2019)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Current scientific evidence does NOT support the use of FBS in clinical practice as its benefits no longer outweigh its risks, and so it will not be performed at Southend Hospital"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "Senior midwifery and medical input should be sought if there is any persistent concern regarding fetal wellbeing."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Management of acute hypoxia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Prolonged deceleration < 10 minutes/baseline bradycardia > 10 minutes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "text": "If a prolonged deceleration occurs for more than 3 minutes, an urgent obstetric review should be sought. In cases of clinically obvious acute intrapartum accidents (i.e. umbilical cord prolapse, placental abruption or uterine rupture), preparations should be made to urgently expedite the birth of the baby, classified as a category 1 birth."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "text": "In the absence of acute accidents, urgent measures should be undertaken to improve utero-placental oxygenation (i.e. changing maternal position, stopping oxytocin (or removal of prostaglandin) or administration of tocolytic or intravenous fluids (i.e. in maternal hypotension), if appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "text": "CTG trace should be carefully scrutinised and if the variability prior to and within the first 3 minutes of the deceleration are normal, and in the absence of other risk factors such as particulate meconium/IUGR and intrapartum accidents with previously normal CTG, then it is appropriate to wait until 9 minutes, observing for signs of recovery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "text": "If there is no recovery by 9 minutes, the woman should be moved to the theatre. If the fetal heart recovers after 9 minutes in the theatre, the decision to deliver should be reconsidered in conjunction with the woman, after considering the overall clinical picture including cervical dilatation, and the rate of progress of labour. This should be discussed with the woman and documented in the notes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "text": "The woman should be advised of the plan and criteria for returning to the room prior to transfer to theatre rather than seeking her opinion under difficult / stressful circumstances in the operating theatre. Normal baseline variability and cycling with clear liquor before the prolonged deceleration/ bradycardia give good prognosis for recovery and good baseline variability during the bradycardia and/or recovery of the FHR is reassuring."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "text": "If immediate transfer to theatre is indicated, the midwife and doctor in the room should commence the bed transfer ensuring that all other necessary staff are contacted and informed of the urgency of the situation. A Category 1 Caesarean Section / Delivery (Obstetric Emergency) call should be activated, if appropriate, to expedite delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Management of gradually evolving hypoxic stress"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "The fetal response needs to be always considered by assessing the presence of a stable baseline fetal heart rate and reassuring baseline variability (5-25 beats/min). An increase in the baseline fetal heart rate with a reassuring baseline FHR variability denotes a \u2018stress' pattern (i.e. due to the release of catecholamines) and measures should be taken to alleviate stress by intrauterine resuscitation. Other causes of increase in baseline FHR / fetal tachycardia such as chorioamnionitis should also be considered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "Be careful:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "text": "Not to confuse tachycardia with decelerations for a normal baseline with accelerations. (If there is no cycling \u2013 active and quiet phases or frequent contractions > 5/10min it is likely to be a decelerative trace)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "text": "Not to mistake overshoots following decelerations for accelerations. Overshoots are considered to be a pre-pathological feature; accelerations will begin from and return to a stable baseline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "Inadvertent recording of maternal pulse, especially if accelerations coincide with uterine contractions or if a previously concerning fetal heart rate suddenly improves. If there is any doubt, auscultate fetal heart with a Pinard stethoscope, apply a FSE, perform an ultrasound scan and/or consider simultaneous monitoring of maternal pulse with the pulse oximeter."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Chorioamnionitis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "It is important to appreciate that chorioamnionitis is a fetal disease and not a maternal disease. Approximately only 8-12% of mothers will show evidence of clinical chorioamnionitis (i.e. tachycardia or pyrexia) in chorioamnionitis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "CTG is a test of intrapartum hypoxia and not infection or inflammation. Any rise in the baseline FHR > 10% without any preceding decelerations (and in the absence of symptoms and signs of maternal dehydration) should be considered as subclinical chorioamnionitis unless proven otherwise."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "prefix": 19.3,
                "text": "The following CTG features have been described with subclinical and clinical chorioamnionitis: please see table 2 below"
            }
        },
        {
            "type": "image",
            "sequence_num": 153,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.005.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "(Galli L et all 2019)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "If there is fetal tachycardia in the presence or absence of cycling and/ or the presence of meconium staining of amniotic fluid (MSAF), then delivery should be advised if a spontaneous or operative vaginal birth is not imminent."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "If there is co-existing hypoxic insult, then the fetal neurological injury increases by approximately 78-fold. Therefore, caution should be exercised whilst continuing uterine contractions or the use of oxytocin infusion (hypoxic stress)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "text": "Maternal pyrexia alone may increase the risk of fetal neurological damage by 3-fold due to increased neuronal metabolic demand and relative oxygen insufficiency. Urgent action should be taken to reduce the maternal temperature."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "text": "There is no clear evidence to suggest when a fetus should be delivered if there is maternal or fetal infection. In view of the lack of clear evidence/guidance on a safe and acceptable time frame for delivery, a clear discussion with the mother should be undertaken with agreed management plan and time frame documented from this. Measures should be taken to treat any pyrexia and infection such as paracetamol, IV fluids and IV antibiotics (see Care in Labour guideline)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "Evidence shows that an intrapartum maternal dose of 1500mg of cefuroxime IV produces effective maternal and fetal concentrations for prophylaxis, but not treatment. It must be noted that CTG, FBS and STAN are not good at predicting fetal well- being or neonatal outcome with Chorioamnionitis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "Please see Appendix 4 CTG Features associated with Chorioamnionitis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Meconium staining of amniotic fluid (MSAF)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "Meconium refers to the first stool passed by the fetus, usually within the first 48 hours of birth and consists of gastrointestinal contents of the fetus. Although, 80% of meconium consists of water, in addition to bile salts, bile acids and bile pigments, it contains gastro-intestinal digestive enzymes (amylases, lipases and proteases), intestinal epithelial cells as well as materials which are constantly swallowed from the amniotic fluid (e.g. fetal lanugo hair, vernix caseosa, inflammatory mediators and desquamated epithelial cells)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "text": "20.1.1 Scientific evidence suggests a stronger association between the passage of meconium and a higher incidence of chorioamnionitis and endometritis. Systemic effects include meconium aspiration syndrome (MAS), which occurs in approximately 11% of all cases of MSAF and is associated with a neonatal mortality rate of 20%."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 0,
                "text": "20.1.2 Presence of any meconium staining of amniotic fluid should be considered as an intrapartum risk factor for infection (chorioamnionitis) and hypoxia (umbilical cord spasm caused by bile salts and bile acids), and continuous electronic fetal heart rate monitoring should be offered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "text": "20.1.3 Co-existing hypoxic stress should be avoided to prevent meconium aspiration syndrome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "text": "20.1.4 If there is a rise in the baseline (or an inappropriate baseline for the given gestational age) and/ or there are repetitive and / or prolonged decelerations and if a spontaneous or vaginal delivery is not imminent (e.g. < 6 cm dilatation), emergency caesarean section should be offered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 0,
                "text": "20.1.5 Reduced baseline variability following a rise in the baseline FHR and/or absence of cycling should warrant an immediate delivery by the quickest and the safest route."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Intrapartum monitoring of a preterm fetus"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Preterm (<32 weeks) \u2013 due to the immaturity of the autonomic nervous system and reduced amount of Wharton's jelly in the umbilical cord, \u2018pathological features' may be observed on the CTG trace even in the absence of hypoxia due to the physiological immaturity of the fetus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "Therefore, women in labour with a fetus of extremely low gestations (24-28 weeks) should be adequately counselled regarding the limitations of CTG monitoring in preterm babies. Consultant input should be sought and then the discussion should be clearly documented."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 0,
                "prefix": 21.3,
                "text": "The management plan should be regularly reviewed as gestation increases. There is paucity of evidence/ guidelines on the use of CTG in Preterm babies and the reader is referred to Review Articles (Please see \u201cReferences\u201d)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 0,
                "prefix": 21.4,
                "text": "Please refer to the Antenatal CTG monitoring-use of Dawes-Redman guideline for monitoring pre-term fetuses, in the absence of uterine contractions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "General principles"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "Discuss with women in suspected, diagnosed or established preterm labour (and their family members or carers as appropriate):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "text": "The purpose of fetal monitoring and what it involves"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "The clinical decisions it informs at different gestational ages"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 0,
                "text": "If appropriate, the option not to monitor the fetal heart rate (for example, at the threshold of viability)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 0,
                "text": "Involve a senior obstetrician in discussions about whether and how to monitor the fetal heart rate for women who are between 23+0 and 25+6 weeks pregnant who are in labour."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "Explain the different fetal monitoring options to the woman (and her family members or carers as appropriate), being aware that:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 180,
            "data": {
                "is_heading": 0,
                "text": "There is limited evidence about the usefulness of specific features to suggest hypoxia or acidosis in preterm babies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 0,
                "text": "The available evidence is broadly consistent with that for babies born at term (see monitoring during labour in the NICE guideline on intrapartum care)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 0,
                "text": "A normal CTG trace is generally reassuring and indicates that the baby is coping well with labour, but an abnormal trace does not necessarily indicate that fetal hypoxia or acidosis is present."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 0,
                "text": "Explain to the woman (and her family members or carers as appropriate) that there is an absence of evidence that using CTG improves the outcomes of preterm labour for the woman or the baby compared with intermittent auscultation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 184,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Cord pH measurement"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 185,
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "Cord blood pH measurements must always be obtained following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 186,
            "data": {
                "is_heading": 0,
                "text": "All emergency caesarean sections and instrumental deliveries."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 187,
            "data": {
                "is_heading": 0,
                "text": "Low Apgar score (<7 at 5 minutes of age) or any baby born in poor condition"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 188,
            "data": {
                "is_heading": 0,
                "text": "Shoulder dystocia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 189,
            "data": {
                "is_heading": 0,
                "text": "Where meconium is present"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 190,
            "data": {
                "is_heading": 0,
                "text": "In cases where ST analysis is used as a further test of fetal well-being"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 191,
            "data": {
                "is_heading": 1,
                "prefix": 23.2,
                "text": "Procedure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 192,
            "data": {
                "is_heading": 0,
                "text": "23.2.1 Double clamp the umbilical cord, isolating about 10cm of cord as soon as possible after the birth (sampling should take place as soon as possible, but will be accurate as long as performed within an hour of delivery)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 193,
            "data": {
                "is_heading": 0,
                "text": "23.2.2 Separate samples must be taken from the umbilical artery and vein (paired samples)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 194,
            "data": {
                "is_heading": 0,
                "text": "23.2.3 The pH should be at least 0.02 units lower in the artery and the pCO2 should be at least 1.0kPa higher in the artery"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 195,
            "data": {
                "is_heading": 1,
                "prefix": 23.3,
                "text": "Acceptable cord gas values"
            }
        },
        {
            "type": "table",
            "sequence_num": 196,
            "data": {
                "num_rows": 4,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "Artery"
                    },
                    {
                        "text": "Vein"
                    },
                    {
                        "text": "pH"
                    },
                    {
                        "text": "7.5 \u2013 7.38"
                    },
                    {
                        "text": "7.17 \u2013 7.48"
                    },
                    {
                        "text": "pCO2"
                    },
                    {
                        "text": "4.9 \u2013 10.7"
                    },
                    {
                        "text": "3.5 \u2013 7.9"
                    },
                    {
                        "text": "BD(ecf)"
                    },
                    {
                        "text": "-2.5 \u2013 10.0"
                    },
                    {
                        "text": "-1.0 \u2013 9.0"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 197,
            "data": {
                "is_heading": 1,
                "prefix": 23.4,
                "text": "Interpretation of results and umbilical cord gases"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 198,
            "data": {
                "is_heading": 0,
                "text": "Low pH, high pCO2 and normal base deficit/base excess = respiratory acidosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 199,
            "data": {
                "is_heading": 0,
                "text": "Low pH and high base deficit in the umbilical artery with normal pH & base deficit in the umbilical vein = short lasting hypoxia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 200,
            "data": {
                "is_heading": 0,
                "text": "Low pH and high base deficit in both the umbilical artery and the vein = longer lasting hypoxia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 201,
            "data": {
                "is_heading": 0,
                "text": "The printout should be securely fixed in the either the mothers or the baby's medical notes, and should be handwritten in the maternity notes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 202,
            "data": {
                "is_heading": 1,
                "prefix": 23.5,
                "text": "Unexpected poor condition at birth"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 203,
            "data": {
                "is_heading": 0,
                "text": "If the baby is unexpectedly depressed at birth, admitted to NNU or the pregnancy is complicated (e.g., preterm / stillborn / abruption / suspected chorioamnionitis) take a swab from between the placental membranes and send the swab for microbiological examination. The placenta should be sent for histopathological examination."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 204,
            "data": {
                "is_heading": 0,
                "text": "In the case of a stillbirth/neonatal death the placenta should be sent at the same time as the baby's body is taken to the mortuary (i.e. the placenta should accompany the baby for the post-mortem examination)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 205,
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Combined continuous fetal monitoring with ST-Analysis (STAN)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 206,
            "data": {
                "is_heading": 1,
                "text": "(will be applicable to Broomfield Hospital when STAN has been implemented)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 207,
            "data": {
                "is_heading": 0,
                "prefix": 24.1,
                "text": "ST Analysis is based on changes in the fetal ECG waveform determined by the myocardial adaptation to oxygen deficiency. It is the computerized real-time analysis of the ST interval of the fetal ECG and should be used in combination with fetal cardiotocography (CTG). In a case of pre-existing fetal hypoxia, the ST change may have already taken place and further ST rise may not occur. Therefore STAN recording should start during the first stage of labour, with ideally a reassuring FHR trace."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 208,
            "data": {
                "is_heading": 0,
                "prefix": 24.2,
                "text": "Monitoring is via a leg plate secured to the woman's thigh (after the skin has been prepared) and application of a STAN spiral fetal scalp electrode. The electrode can be applied to the fetal scalp by twisting the electrode clockwise with the lead wires secured within the slot at the head of the applicator. The electrode can be removed by maintaining a gentle traction on the wire while twisting it anti-clockwise."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 209,
            "data": {
                "is_heading": 0,
                "prefix": 24.3,
                "text": "At start-up manual data analysis is required until the \u201cBaseline T/QRS determined\u201d message appears in the Event Log. Pause in the recording or poor signal quality with gaps in the T/QRS ratios for more than 4 minutes may result in missed ST Events."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 210,
            "data": {
                "is_heading": 1,
                "prefix": 30.0,
                "text": "Signal quality - all STAN traces must be continually evaluated for signal quality. Each x at the bottom of the trace represents 30 TQRS complexes (or  beats of the fetal heart). If there are no x's the event log will display a poor signal quality message. If there is poor signal quality STAN is not working and in such cases ST analysis should not be used and disabled."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 211,
            "data": {
                "is_heading": 0,
                "prefix": 24.5,
                "text": "Prerequisites prior to commencing STAN"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 212,
            "data": {
                "is_heading": 0,
                "text": "Maternal or fetal risk factors"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 213,
            "data": {
                "is_heading": 0,
                "prefix": 36.0,
                "text": "Gestation \u2265  weeks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 214,
            "data": {
                "is_heading": 0,
                "text": "Membranes have ruptured"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 215,
            "data": {
                "is_heading": 0,
                "text": "No contraindications to FSE"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 216,
            "data": {
                "is_heading": 0,
                "text": "First stage of labour (no active pushing at onset)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 217,
            "data": {
                "is_heading": 1,
                "prefix": 24.6,
                "text": "After start-up"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 218,
            "data": {
                "is_heading": 0,
                "text": "Normal ECG waveform with sufficient signal quality"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 219,
            "data": {
                "is_heading": 0,
                "text": "Event log message baseline determined"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 220,
            "data": {
                "is_heading": 0,
                "text": "Check for reactivity and non-deteriorating fetal state at the onset of STAN recording, classify the FHR"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 221,
            "data": {
                "is_heading": 1,
                "prefix": 24.7,
                "text": "STAN must not be commenced on a pre-terminal trace and the baby should be delivered immediately."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 222,
            "data": {
                "is_heading": 1,
                "prefix": 24.8,
                "text": "How to manage an abnormal CTG with no ST event/s"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 223,
            "data": {
                "is_heading": 0,
                "text": "24.8.1 Should the CTG be abnormal for more than 60 minutes, or less if the FHR deteriorates rapidly, with normal ST data then qualified assessment is required in order to check for a non-deteriorating fetal state. This is crucial in active second stage. With a preterminal CTG pattern, intervention is always indicated, irrespective of ST data."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 224,
            "data": {
                "is_heading": 1,
                "prefix": 24.9,
                "text": "ST Events"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 225,
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "24.9.1 The type of ST events indicate situations in which intervention is required as described in Appendix  Intervention depends on the cause of fetal compromise and the stage of labour. It includes qualified assessment of the CTG pattern, alleviation of cause(s) of fetal distress (such as over-stimulation or maternal hypotension) and delivery. During second stage with active pushing, intervention means that immediate operative delivery is recommended unless spontaneous delivery is anticipated within the next 5-10 minutes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 226,
            "data": {
                "is_heading": 0,
                "text": "24.9.2 The ST events are classified as follows:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 227,
            "data": {
                "is_heading": 0,
                "text": "Episodic T/QRS rise"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 228,
            "data": {
                "is_heading": 0,
                "text": "Baseline T/QRS rise"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 229,
            "data": {
                "is_heading": 0,
                "text": "Biphasic ST event"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 230,
            "data": {
                "is_heading": 1,
                "prefix": 24.1,
                "text": "Episodic T/QRS Rise"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 231,
            "data": {
                "is_heading": 0,
                "text": "Indicates short lasting hypoxia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 232,
            "data": {
                "is_heading": 0,
                "text": "Lasts for less than 10 minutes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 233,
            "data": {
                "is_heading": 0,
                "text": "Is significant if >0.10"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 234,
            "data": {
                "is_heading": 0,
                "text": "Management depends on the CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 235,
            "data": {
                "is_heading": 1,
                "prefix": 24.11,
                "text": "Baseline T/QRS"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 236,
            "data": {
                "is_heading": 0,
                "text": "Indicates the fetus is responding to continued hypoxia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 237,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "Lasts longer than  minutes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 238,
            "data": {
                "is_heading": 0,
                "text": ">0.05 is significant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 239,
            "data": {
                "is_heading": 1,
                "prefix": 24.12,
                "text": "Biphasic ST event"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 240,
            "data": {
                "is_heading": 0,
                "text": "Fetus has a reduced oxygen supply"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 241,
            "data": {
                "is_heading": 0,
                "text": "Three possible causes: Fetal heart cannot respond to hypoxia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 242,
            "data": {
                "is_heading": 0,
                "text": "Reduced capability to respond"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 243,
            "data": {
                "is_heading": 0,
                "text": "Heart muscle dysfunction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 244,
            "data": {
                "is_heading": 1,
                "prefix": 24.13,
                "text": "Escalation of ST events - should a ST event occur this should be discussed with the Obstetric Registrar and a plan made. Interpretation of an ST event must include an assessment of the entire CTG and clinical situation. Immediate escalation to the obstetrician should occur in the event of abnormal / pre-terminal CTG Maternal pyrexia/suspected chorioamnionitis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 245,
            "data": {
                "is_heading": 1,
                "prefix": 24.14,
                "text": "STAN and infection/chorioamnionitis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 246,
            "data": {
                "is_heading": 0,
                "text": "24.14.1 STAN is used to detect acute intrapartum hypoxia not fetal infections and should be managed with caution in the presence of maternal pyrexia/fetal tachycardia/suspected chorioamnionitis, where delivery may be indicated without ST changes, as fetal damage may occur secondary to inflammation/inflammatory mediators without evidence of hypoxia. Moreover, maternal pyrexia inflammatory mediators may lower the threshold for hypoxic brain damage. In the presence of maternal pyrexia even intermediary CTG pattern may be regarded as significant in combination with ST Event."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 247,
            "data": {
                "is_heading": 1,
                "text": "24.14.2 WARNING: ST analysis is only an adjunct to fetal heart rate monitoring and should never be used exclusively to make patient management decisions. There are situations in which the fetus is experiencing hypoxia but an automatic ST event signal may not appear. These include the following:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 248,
            "data": {
                "is_heading": 0,
                "text": "Inadequate time to obtain baseline ECG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 249,
            "data": {
                "is_heading": 0,
                "text": "Poor signal quality"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 250,
            "data": {
                "is_heading": 0,
                "text": "Pre-existing hypoxia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 251,
            "data": {
                "is_heading": 0,
                "text": "24.14.3 If there is reason to believe that any of the above applies, clinical decision making should not include ST analysis and this should be disabled."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 252,
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Fresh eyes approach"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 253,
            "data": {
                "is_heading": 0,
                "prefix": 25.1,
                "text": "This should involve assessing any changes in the baseline FHR (i.e. catecholamine surge or infection), evidence of continued central organ oxygenation (i.e. a stable baseline and reassuring variability), presence of cycling and onset of additional intrapartum risk factors (fresh meconium, maternal pyrexia, epidural, oxytocin infusion) etc. Documentation of this should occur on CTG assessment tool (appendix 2)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 254,
            "data": {
                "is_heading": 0,
                "prefix": 25.2,
                "text": "\u201cFresh Eyes\u201d is recommended every hour, or more frequently if there are additional concerns (e.g. meconium during labour, chorioamnionitis or intrapartum bleeding). This should be done by the labour ward co-ordinator, 2nd band 7 on duty, or if both unavailable, another senior band 6 midwife. There may be times when there is a difference of opinion regarding the classification of the CTG or the plan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 255,
            "data": {
                "is_heading": 0,
                "prefix": 25.3,
                "text": "On occasions when the case midwife and the \u201cfresh eyes\u201d reviewer disagree; a further review should be requested from the coordinator or middle grade/senior obstetrician. On the rare occasion when an agreement is still not met, any member of the team interpreting the CTG should have the opportunity to ask for a \u201cCTG huddle\u201d. This would involve the team (case midwife, senior midwife, registrar, the consultant and fetal surveillance midwife if available and any other persons requested) coming together to discuss the case in its entirety. The aim of this being that everyone has the opportunity to air their concerns, discuss the relevant pathophysiology and make a plan of care away from the woman. The woman should then be informed of the discussion and the recommended plan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 256,
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "Use of Oxytocin to augment labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 257,
            "data": {
                "is_heading": 0,
                "prefix": 26.1,
                "text": "Oxytocin increases the frequency, duration and strength of the uterine contractions, and also may increase the basal tone of the uterus, which may compromise the ability of a fetus to ensure effective gaseous exchange in between the contractions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 258,
            "data": {
                "is_heading": 0,
                "prefix": 26.2,
                "text": "Use of oxytocin may increase the risk of fetal hypoxic-ischaemic injury. Therefore, in the absence of a stable baseline appropriate for the given gestational age and normal variability and cycling, oxytocin should not be commenced. Consultant input should be sought."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 259,
            "data": {
                "is_heading": 0,
                "prefix": 26.3,
                "text": "Consultant input should be sought prior to commencing oxytocin in cases of suspected subclinical or clinical chorioamnionitis because super-imposed hypoxia can significantly increase the risk of fetal neurological injury."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 260,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "Uterine hyperstimulation should be diagnosed based on increased uterine activity (i.e. frequency, duration or strength) associated with CTG changes, and not by the frequency of uterine contractions (>in  minutes) alone."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 261,
            "data": {
                "is_heading": 0,
                "prefix": 26.5,
                "text": "In the presence of meconium staining of amniotic fluid, hypoxia and acidosis can significantly increase the risk of meconium staining of amniotic fluid. Therefore, oxytocin should be used with caution in the presence of meconium staining  of amniotic fluid and consultant input should be sought."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 262,
            "data": {
                "is_heading": 0,
                "prefix": 26.6,
                "text": "Uterine myometrium has maximum myometrial receptors during second stage of labour. Therefore, if oxytocin is deemed necessary during second stage of labour to achieve progress, then, subacute hypoxic pattern and the ZigZag Pattern should be excluded."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 263,
            "data": {
                "is_heading": 1,
                "prefix": 27.0,
                "text": "Fetal heart rate monitoring during low risk labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 264,
            "data": {
                "is_heading": 0,
                "prefix": 27.1,
                "text": "This is recommended only for low risk labour with presumed low probability of fetal hypoxic injury. Risks, benefits and alternatives should be discussed with the woman and documented in the notes. Intermittent auscultation should be recommended routinely in the absence of utero-placental insufficiency and in the absence of any maternal or fetal condition that increases intrapartum fetal hypoxic injury. Please see Appendix 5 List of indications for continuous CTG monitoring."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 265,
            "data": {
                "is_heading": 1,
                "prefix": 27.2,
                "text": "Principles of intermittent (intelligent) auscultation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 266,
            "data": {
                "is_heading": 0,
                "text": "27.2.1 Maternal pulse should be recorded at the commencement of auscultation of fetal heart rate in labour, and documented on the partogram and in the notes. This should then be repeated hourly, and it should be documented on the partogram."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 267,
            "data": {
                "is_heading": 0,
                "text": "27.2.2 Intermittent auscultation should be carried out using hand held Doppler or the Pinard Stethoscope."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 268,
            "data": {
                "is_heading": 0,
                "text": "27.2.3 If there is clinical suspicion that the maternal pulse is being auscultated, such as a change in the baseline fetal heart rate or difficulty auscultating the fetal heart, both fetal and maternal heart rate should be monitored simultaneously. A fetal scalp electrode (FSE) should be applied with the woman's consent when there is inadequate abdominal recording as poor quality traces are unacceptable (avoid FSE with HIV, Hep B and C and bleeding disorders unless clearly documented as suitable)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 269,
            "data": {
                "is_heading": 0,
                "text": "27.2.4 Initial assessment should follow the principles of \u2018intelligent auscultation' whereby clinicians should record the baseline fetal heart rate and then auscultate during fetal movement or following stimulation of the baby. At that time, acceleration should be noted and the presence of chronic hypoxia can be excluded."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 270,
            "data": {
                "is_heading": 0,
                "prefix": 15.0,
                "text": "27.2.5 Following this, in the active stage of labour, intermittent auscultation should occur immediately after a palpated contraction for a minimum of 60 seconds and at least: every  minutes in the first stage and documented on the partogram."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 271,
            "data": {
                "is_heading": 0,
                "text": "27.2.6 Auscultate at least every 5 minutes or after every contraction in second stage, and document on the partogram in order to be alert to rise in baseline during this period."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 272,
            "data": {
                "is_heading": 0,
                "text": "27.2.7 Increased vigilance with regard to fetal heart monitoring is needed when second stage is suspected as the fetus is at greater risk of compromise due the increased frequency, strength and duration of the contractions, and the mechanical effects from the descent of the fetus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 273,
            "data": {
                "is_heading": 0,
                "text": "27.2.8 All fetal heart rates should be recorded as a single number and not a range."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 274,
            "data": {
                "is_heading": 1,
                "prefix": 27.3,
                "text": "When to transfer from intermittent auscultation to continuous EFM"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 275,
            "data": {
                "is_heading": 0,
                "text": "Any meconium stained liquor"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 276,
            "data": {
                "is_heading": 0,
                "text": "Abnormal FHR detected by intermittent auscultation (less than 110 bpm; greater than 160 bpm; any deceleration or acceleration heard after a contraction)*"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 277,
            "data": {
                "is_heading": 0,
                "text": "Temperature of 38\u00b0C or above on a single reading, or 37.5\u00b0C or above on 2 consecutive occasions 1 hour apart"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 278,
            "data": {
                "is_heading": 0,
                "text": "Fresh bleeding developing in labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 279,
            "data": {
                "is_heading": 0,
                "text": "Oxytocin use for augmentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 280,
            "data": {
                "is_heading": 0,
                "text": "Epidural analgesia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 281,
            "data": {
                "is_heading": 0,
                "text": "Prolonged second stage of labour i.e. inadequate progress after 1 hour of active second stage"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 282,
            "data": {
                "is_heading": 0,
                "text": "Severe hypertension 160/110 or above (NICE, 2014)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 283,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Moderate hypertension 140/90 on 2 consecutive readings  minutes apart"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 284,
            "data": {
                "is_heading": 0,
                "text": "2+ protein on urinalysis with a single reading of 140/90 or above."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 285,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Maternal pulse of 120 or more on 2 occasions  minutes apart."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 286,
            "data": {
                "is_heading": 0,
                "text": "Contractions > 5:10, or hypertonic uterine dysfunction (contractions lasting 2mins or more)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 287,
            "data": {
                "is_heading": 1,
                "prefix": 27.4,
                "text": "Concerns during intelligent intermittent auscultation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 288,
            "data": {
                "is_heading": 0,
                "text": "27.4.1 If there is a rising baseline fetal heart rate or decelerations are suspected on intermittent auscultation the differential diagnoses include: sub-acute or evolving hypoxia, chorioamnionitis or tachycardia secondary to maternal pyrexia/tachycardia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 289,
            "data": {
                "is_heading": 0,
                "text": "27.4.2 Actions should include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 290,
            "data": {
                "is_heading": 0,
                "text": "Carrying out intermittent auscultation more frequently, for example after 3 consecutive contractions initially."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 291,
            "data": {
                "is_heading": 0,
                "text": "Think about the entire clinical picture, including the woman's position and hydration, the strength and frequency of contractions and maternal observations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 292,
            "data": {
                "is_heading": 0,
                "text": "27.4.3 If a rising baseline or decelerations are confirmed, further actions should include:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 293,
            "data": {
                "is_heading": 0,
                "text": "Summoning help, recommending immediate continuous cardiotocography, and explaining to the woman and her birth companion(s) why it is needed, transferring the woman to obstetric-led care, provided that it is safe and appropriate to do so."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 294,
            "data": {
                "is_heading": 0,
                "text": "Additionally, the presence of accelerations after each uterine contraction may reflect ongoing \u2018overshoots' of variable decelerations. Therefore, if repeated accelerations are heard after uterine contractions it is recommended that the fetal heart rate is auscultated during and after the next three uterine contractions, to detect the presence of a deceleration followed by an overshoot."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 295,
            "data": {
                "is_heading": 0,
                "text": "27.4.4 If there is an indication to change the method of monitoring this must be clearly documented in the medical notes. If continuous monitoring is advised but declined, the risks of not continuously monitoring should be explained and the midwife in charge and Registrar informed, and all discussions documented. They should also be informed if outside influences are thought to be affecting the woman's decision making. If continuous cardiotocography has been started because of concerns arising from intermittent auscultation, but the trace is normal after 60 minutes, return to intermittent auscultation unless the woman requests to continue CTG monitoring and in agreement/fresh eyes with CDS coordinator."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 296,
            "data": {
                "is_heading": 1,
                "prefix": 27.5,
                "text": "Fresh eyes for intermittent auscultation (IA)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 297,
            "data": {
                "is_heading": 0,
                "text": "27.5.1 For intermittent auscultation in established labour on MLBU or at home, 2 midwives must sign the fresh eyes review hourly (see appendix 3). For midwives at homebirths who do not have a second midwife or if no one is available to do fresh eyes for women on MLBU, the case midwife should still do a fresh eyes sticker hourly. This ensures the entire clinical picture is considered and prompts action if concerns arise from intelligent IA."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 298,
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Training requirements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 299,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "All Midwives and Obstetricians of all grades must attend trust CTG training session and pass competency assessment every  months, as per Saving Babies' Lives Care Bundle version 2 (NHS England 2019). Pass mark 80%."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 300,
            "data": {
                "is_heading": 0,
                "prefix": 28.2,
                "text": "Staff who do not pass the mandatory competency assessment will be informed within 72 hours of the assessment. All staff with marks below 70% will need to be retrained and reassessed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 301,
            "data": {
                "is_heading": 0,
                "prefix": 28.3,
                "text": "Midwives who receive results between 70-79% will need to meet with the Fetal Surveillance Midwife for feedback and reassessment within 2 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 302,
            "data": {
                "is_heading": 0,
                "prefix": 28.4,
                "text": "Obstetric Registrars and Senior House Officers who receive results between 70- 79% are to meet with their educational supervisor for feedback and reassessment within 2 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 303,
            "data": {
                "is_heading": 0,
                "prefix": 28.5,
                "text": "Obstetric Consultants who receive results between 70-79% will meet with the Clinical Director for feedback and reassessment within 2 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 304,
            "data": {
                "is_heading": 0,
                "prefix": 28.6,
                "text": "Staff who do not pass the assessment may be redeployed to an area where fetal monitoring is not required following discussion with their appropriate senior management team. This would be coordinated by the Fetal Surveillance Midwife."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 305,
            "data": {
                "is_heading": 0,
                "prefix": 28.7,
                "text": "All staff members are entitled to review their assessment paper and challenge the mark if they are able to provide evidence that the grading is incorrect. In this case, a second marker will be assigned to review the case independently."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 306,
            "data": {
                "is_heading": 0,
                "prefix": 28.8,
                "text": "Flowchart of action to be taken if annual competency assessment on Fetal Monitoring (including Cardiotocographs and Intermittent Auscultation) is not passed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 307,
            "data": {
                "is_heading": 0,
                "text": "(Refer to page 29)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 308,
            "data": {
                "is_heading": 1,
                "text": "mark"
            }
        },
        {
            "type": "image",
            "sequence_num": 309,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.006.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 310,
            "data": {
                "is_heading": 1,
                "text": "Repeat training and assessment"
            }
        },
        {
            "type": "image",
            "sequence_num": 311,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.007.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 312,
            "data": {
                "is_heading": 0,
                "text": "Consideration by the senior management team to redeploy staff member to an area where fetal monitoring is not required until assessment is passed."
            }
        },
        {
            "type": "image",
            "sequence_num": 313,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.008.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 314,
            "data": {
                "is_heading": 1,
                "text": "70-79% mark"
            }
        },
        {
            "type": "image",
            "sequence_num": 315,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.009.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 316,
            "data": {
                "is_heading": 0,
                "text": "Fetal monitoring in labour / MEHT-21011/1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 317,
            "data": {
                "is_heading": 1,
                "prefix": 52.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 318,
            "data": {
                "is_heading": 1,
                "text": "Midwives"
            }
        },
        {
            "type": "image",
            "sequence_num": 319,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.010.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 320,
            "data": {
                "is_heading": 0,
                "text": "Fetal Surveillance"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 321,
            "data": {
                "is_heading": 0,
                "text": "M  idwife to facilitate a 1:1 constructive"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 322,
            "data": {
                "is_heading": 0,
                "text": "fe  edback session. Re- assessment within 2"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 323,
            "data": {
                "is_heading": 0,
                "text": "w eeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 324,
            "data": {
                "is_heading": 1,
                "text": "SHO/Registrars Doctors"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 325,
            "data": {
                "is_heading": 0,
                "text": "To meet with their educational supervisor for a 1:1 constructive feedback and re- assessment within 2 weeks."
            }
        },
        {
            "type": "image",
            "sequence_num": 326,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.011.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 327,
            "data": {
                "is_heading": 1,
                "text": "Consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 328,
            "data": {
                "is_heading": 0,
                "text": "Meet with the Clinical Director for a 1:1 constructive feedback and re-assessment within 2 weeks."
            }
        },
        {
            "type": "image",
            "sequence_num": 329,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.012.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 330,
            "data": {
                "is_heading": 1,
                "prefix": 29.0,
                "text": "Dawes Redman"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 331,
            "data": {
                "is_heading": 1,
                "prefix": 29.1,
                "text": "Aims and objectives"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 332,
            "data": {
                "is_heading": 0,
                "text": "To assess antepartum fetal wellbeing, provide ongoing assessment of the fetus \u201cat risk\u201d, and aid in deciding optimum timing for delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 333,
            "data": {
                "is_heading": 0,
                "text": "Have a standardised and objective way of monitoring the fetal heart rate in the antenatal period, provide consistent interpretation of CTG and eliminate inter- and intra-observer variations that are associated with subjective visual interpretation of conventional CTG."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 334,
            "data": {
                "is_heading": 0,
                "text": "Reduced monitoring time."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 335,
            "data": {
                "is_heading": 0,
                "text": "Electronic archiving of the CTG to be used for audit and educational purposes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 336,
            "data": {
                "is_heading": 0,
                "text": "Trend analysis of Short Term Variation (STV) may aid in deciding optimum timing of delivery of a fetus with chronic hypoxia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 337,
            "data": {
                "is_heading": 1,
                "text": "29.1.2 Limitations of Dawes Redman"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 338,
            "data": {
                "is_heading": 0,
                "text": "Sonicaid FetalCare is intended as an adjunct to, and not a replacement for, an expert visual assessment of a FHR trace."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 339,
            "data": {
                "is_heading": 0,
                "text": "Sonicaid FetalCare is an aid to clinical management but not a diagnosis, which remains the responsibility of an appropriately qualified expert."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 340,
            "data": {
                "is_heading": 0,
                "text": "Both the expert visual assessment and the analysis provided by Sonicaid FetalCare should be considered within the context of a full clinical assessment before decisions are made regarding management. Such an assessment may include further tests such as ultrasound scan and fetal Doppler velocimetry or biophysical profiling."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 341,
            "data": {
                "is_heading": 0,
                "text": "It should be noted that a normal trace does not give an absolute guarantee that a fetus is safe. A reassuring trace cannot anticipate a placental abruption. Whilst these catastrophic events happen, in pregnancies where the deterioration is gradual, FetalCare can help predict when delivery is likely to become necessary."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 342,
            "data": {
                "is_heading": 1,
                "text": "29.1.3 Eligibility for using the Dawes Redman analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 343,
            "data": {
                "is_heading": 0,
                "text": "Dawes Redman analysis is the preferred method of monitoring antenatally in high risk pregnancies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 344,
            "data": {
                "is_heading": 0,
                "text": "Dawes Redman analysis can be used whilst women are experiencing Braxton Hicks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 345,
            "data": {
                "is_heading": 0,
                "text": "Dawes Redman analysis is invalid in labour, and should also not be used during induction of labour. Any CTGs performed for induction of labour should be performed on a Philips CTG monitor; if there is not one available then the Dawes Redman analysis should not be turned on."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 346,
            "data": {
                "is_heading": 0,
                "text": "Any CTG performed in the antenatal period for a non-labouring reason should be performed on the Oxford machines and there should be no switching from an oxford machine to a Philips if any concerns arise."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 347,
            "data": {
                "is_heading": 0,
                "text": "Analysis can be used for both singleton and twin pregnancy."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 348,
            "data": {
                "is_heading": 1,
                "text": "29.1.4 Instructions on how to set up the Dawes Redman analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 349,
            "data": {
                "is_heading": 0,
                "text": "Set up the machine as normal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 350,
            "data": {
                "is_heading": 0,
                "text": "Input hospital number and Gestation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 351,
            "data": {
                "is_heading": 0,
                "text": "Ensure that the woman's details as listed in point 3.5.1 are documented at the beginning of the recording. Check the time and date on the machine are correct and tick to indicate this."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 352,
            "data": {
                "is_heading": 0,
                "text": "Give the woman the fetal activity marker button"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 353,
            "data": {
                "is_heading": 0,
                "text": "Start the analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 354,
            "data": {
                "is_heading": 0,
                "text": "Once the criteria has met and the whole clinical picture has been reviewed stop the recording."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 355,
            "data": {
                "is_heading": 0,
                "text": "Two health care professionals review, sign and date the CTG prior to being filed in the CTG envelope."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 356,
            "data": {
                "is_heading": 1,
                "text": "29.1.5 Interpreting Dawes Redman analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 357,
            "data": {
                "is_heading": 0,
                "text": "The machine can meet criteria as quickly as 10 minutes and as long as 60 minutes, once the criteria has met the CTG must be interpreted using the Antenatal CTG assessment sticker. See the flow chart below."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 358,
            "data": {
                "is_heading": 0,
                "text": "If the analysis has been on for less than 60 minutes and has still not met but there are clear concerns then earlier intervention and escalation should be carried out as appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 359,
            "data": {
                "is_heading": 0,
                "prefix": 60.0,
                "text": "Unless there are clear abnormal features continue the trace for the whole  minutes if it has not met, stopping the analysis before the criteria met and before 60minutes will result in an invalid analysis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 360,
            "data": {
                "is_heading": 0,
                "text": "Criteria Met?"
            }
        },
        {
            "type": "image",
            "sequence_num": 361,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.013.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 362,
            "data": {
                "is_heading": 0,
                "text": "Yes  No"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 363,
            "data": {
                "is_heading": 0,
                "text": "Is the CTG Normal as"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 364,
            "data": {
                "is_heading": 0,
                "text": "per the Antenatal CTG  Hascon ttahcetr oe nb teheen CgToGo?d"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 365,
            "data": {
                "is_heading": 0,
                "text": "sticker?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 366,
            "data": {
                "is_heading": 0,
                "text": "Yes - referral to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 367,
            "data": {
                "is_heading": 0,
                "text": "No - For obstetric  obstetrician for further"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 368,
            "data": {
                "is_heading": 0,
                "text": "YePisc -t uIsr et hneo crmlinalic?a l   clinical picture.  whole clinical picture.  analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 369,
            "data": {
                "is_heading": 0,
                "text": "Review of the CTG and  review of analysis and  No - Repeat CTG and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 370,
            "data": {
                "is_heading": 0,
                "text": "Yes - Discontinue CTG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 371,
            "data": {
                "is_heading": 0,
                "text": "and continue with  No - For obstetric"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 372,
            "data": {
                "is_heading": 0,
                "text": "planned care.  review"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 373,
            "data": {
                "is_heading": 1,
                "text": "Always consider the interpretations of the CTG in association with all other assessments of the woman, including clinical condition, fetal assessment, USS and other investigations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 374,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix 8 for how the analysis works)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 375,
            "data": {
                "is_heading": 1,
                "text": "29.1.6 Reasons for not meeting criteria (and the codes)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 376,
            "data": {
                "is_heading": 0,
                "text": "Basal heart rate outside normal range"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 377,
            "data": {
                "is_heading": 0,
                "text": "Large deceleration"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 378,
            "data": {
                "is_heading": 0,
                "text": "No episodes of high variation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 379,
            "data": {
                "is_heading": 0,
                "text": "No movements and fewer than 3 accelerations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 380,
            "data": {
                "is_heading": 0,
                "text": "Baseline fitting is uncertain"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 381,
            "data": {
                "is_heading": 0,
                "text": "Short term variation less than 3ms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 382,
            "data": {
                "is_heading": 0,
                "text": "Possible error at the end of the record"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 383,
            "data": {
                "is_heading": 0,
                "text": "Deceleration at the end of the record"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 384,
            "data": {
                "is_heading": 0,
                "text": "High frequency sinusoidal rhythm"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 385,
            "data": {
                "is_heading": 0,
                "text": "Suspected sinusoidal rhythm"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 386,
            "data": {
                "is_heading": 0,
                "text": "LTV in episodes of high variation is below the acceptable level"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 387,
            "data": {
                "is_heading": 0,
                "text": "No accelerations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 388,
            "data": {
                "is_heading": 1,
                "text": "29.1.7 Single and double asterisks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 389,
            "data": {
                "is_heading": 0,
                "text": "Double asterisks indicates one of the following conditions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 390,
            "data": {
                "is_heading": 0,
                "text": "Fetal heart rate <110 or > 160 bpm on a record less than 30 Minutes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 391,
            "data": {
                "is_heading": 0,
                "text": "Decelerations > 100 lost beats"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 392,
            "data": {
                "is_heading": 0,
                "text": "No movements and fewer than 3 accelerations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 393,
            "data": {
                "is_heading": 0,
                "text": "No episodes of high variation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 394,
            "data": {
                "is_heading": 0,
                "text": "Short term variation < 3ms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 395,
            "data": {
                "is_heading": 0,
                "text": "No accelerations and either <21 movements per hour or long term variation in episodes of high variation below the tenth centile"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 396,
            "data": {
                "is_heading": 0,
                "text": "Long term variation in episodes of high variation below the first centile."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 397,
            "data": {
                "is_heading": 0,
                "text": "A single asterisk indicates one of the following conditions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 398,
            "data": {
                "is_heading": 0,
                "text": "Short term variation <4 ms, but > 3ms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 399,
            "data": {
                "is_heading": 0,
                "text": "Basal heart rate <110 bpm or > 160 bpm on a record > 30 minutes"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 400,
            "data": {
                "is_heading": 0,
                "text": "Decelerations present, but not meeting criteria for size or record length"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 401,
            "data": {
                "is_heading": 1,
                "text": "A single asterisk does not necessarily mean that the record cannot pass the criteria. Referral to the registrar for a plan of care should be made."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 402,
            "data": {
                "is_heading": 1,
                "text": "29.1.8 High Variation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 403,
            "data": {
                "is_heading": 1,
                "text": "If criteria met repeat CTG at intervals suggested by appropriate clinical situation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 404,
            "data": {
                "is_heading": 1,
                "text": "If high variation is reduced (criteria not met) assess short term variation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 405,
            "data": {
                "is_heading": 1,
                "text": "29.1.9 Short Term Variation (when \u2018criteria is not met')"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 406,
            "data": {
                "is_heading": 1,
                "text": "STV (ms)  >4  3.5 - 4"
            }
        },
        {
            "type": "image",
            "sequence_num": 407,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.014.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 408,
            "data": {
                "is_heading": 0,
                "text": "Action  Repeat  Repeat  Repeat  Urgent twice  Daily  twice daily  Review by"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 409,
            "data": {
                "is_heading": 0,
                "text": "weekly  (must be  Obstetrician reviewed by"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 410,
            "data": {
                "is_heading": 0,
                "text": "obstetrician)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 411,
            "data": {
                "is_heading": 1,
                "prefix": 30.0,
                "text": "Day assessment in the stand alone units"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 412,
            "data": {
                "is_heading": 0,
                "prefix": 30.1,
                "text": "See the inclusion and exclusion criteria for women attending the low risk birthing units for review in the Triage SOP 20012."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 413,
            "data": {
                "is_heading": 0,
                "prefix": 30.2,
                "text": "CTGs can be performed for the following women:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 414,
            "data": {
                "is_heading": 0,
                "text": "Reduced fetal movements \u2013 first episode"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 415,
            "data": {
                "is_heading": 0,
                "text": "On going reduced fetal movements in accordance with the Reduced fetal movements guideline (06034)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 416,
            "data": {
                "is_heading": 0,
                "text": "Routine CTG's for ongoing reduced movements following an obstetric review and ultrasound"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 417,
            "data": {
                "is_heading": 0,
                "text": "CTGs for women having regular CTGs following an obstetric review and ultrasound"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 418,
            "data": {
                "is_heading": 0,
                "text": "CTGs for IUGR following an obstetric review as part of an obstetric plan"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 419,
            "data": {
                "is_heading": 0,
                "text": "(Refer to the Reduced Fetal Movement Guideline 06034)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 420,
            "data": {
                "is_heading": 0,
                "prefix": 30.3,
                "text": "Following completion of any CTG, where the second midwife is not present in the Midwife-led Unit (MLU); i.e. during a night shift; the responsible midwife should fax the CTG to the Labour Ward for a second opinion and signature. The signed CTG should then be faxed back to the responsible midwife at the MLU and filed according to local guidance. (Refer to the guideline entitled \u2018Guideline for Maternity Record Keeping; register number 06036)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 421,
            "data": {
                "is_heading": 0,
                "prefix": 30.4,
                "text": "If a midwife has a concern with a CTG this should be faxed to the Labour Ward and the midwife should discuss with the duty registrar formulating a plan of care."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 422,
            "data": {
                "is_heading": 0,
                "prefix": 30.4,
                "text": "In the case of an abnormal CTG, the CTG should be faxed to Labour Ward and immediate arrangements made to transfer the patient by ambulance to the Labour Ward. The labour Ward Co-ordinator and obstetrician should be informed of imminent transfer. Prior to transfer the  midwife should take appropriate conservative measures and when possible site a venflon and take blood for full blood count (FBC) and group and save."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 423,
            "data": {
                "is_heading": 1,
                "prefix": 31.0,
                "text": "Monitoring and audit"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 424,
            "data": {
                "is_heading": 1,
                "prefix": 31.1,
                "text": "Each document must outline the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            }
        },
        {
            "type": "table",
            "sequence_num": 425,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monito ring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Fetal monitoring element of Saving Babies Lives audit measuring the use of fresh eyes checks in labour for CTG and intermittent auscultation and escalation of fetal monitoring concerns."
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "Fetal surveillance midwife"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Saving Babies Lives Committee"
                    },
                    {
                        "text": "Head of Midwifery"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 426,
            "data": {
                "is_heading": 1,
                "prefix": 32.0,
                "text": "Approval and implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 427,
            "data": {
                "is_heading": 0,
                "prefix": 32.1,
                "text": "All policies, procedures and guidelines will be approved by the Obstetrics and Gynaecology Guideline Steering Group, which is the specialist group with the authority to approve local documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 428,
            "data": {
                "is_heading": 0,
                "prefix": 32.2,
                "text": "It is the author's responsibility to inform the stakeholders of the approved policy documents when they are uploaded to the Trust's Intranets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 429,
            "data": {
                "is_heading": 1,
                "prefix": 33.0,
                "text": "Equality impact assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 430,
            "data": {
                "is_heading": 1,
                "prefix": 33.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 431,
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 9)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 432,
            "data": {
                "is_heading": 1,
                "prefix": 34.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 433,
            "data": {
                "is_heading": 0,
                "text": "Ayres-de-Campos D et al, (2015). FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. Available at: https://obgyn.onlinelibrary.wiley.com/doi/10.1016/j.ijgo.2015.06.020"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 434,
            "data": {
                "is_heading": 0,
                "text": "Physiological CTG interpretation: intrapartum fetal monitoring guideline, (2018). Available at:physiological-ctg.com/guideline.html"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 435,
            "data": {
                "is_heading": 0,
                "text": "NHS England 2019 Saving Babies' Lives Version Two: a care bundle for reducing perinatal mortality.."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 436,
            "data": {
                "is_heading": 0,
                "text": "Available at : https://www.england.nhs.uk/publication/saving-babies-lives-version- two-a-care-bundle-for-reducing-perinatal-mortality/"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 437,
            "data": {
                "is_heading": 0,
                "text": "NICE, (2014). Intrapartum care for healthy women and babies [CG 190]. Available at: https://www.nice.org.uk/guidance/cg190"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 438,
            "data": {
                "is_heading": 1,
                "prefix": 35.0,
                "text": "Bibliography"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 439,
            "data": {
                "is_heading": 0,
                "text": "Afors K, Chandraharan E. Use of continuous electronic fetal monitoring in a preterm fetus: clinical dilemmas and recommendations for practice. J Pregnancy. 2011;2011:848794."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 440,
            "data": {
                "is_heading": 0,
                "text": "Al Wattar BH, Lakhiani A, Sacco A, et al. Evaluating the value of intrapartum fetal scalp blood sampling to predict adverse neonatal outcomes: A UK multicentre observational study. Eur J Obstet Gynecol Reprod Biol. 2019;240:62-67. doi:10.1016/j.ejogrb.2019.06.012"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 441,
            "data": {
                "is_heading": 0,
                "text": "Amer-W\u00e5hlin I, Hellsten C, Nor\u00e9n H, Hagberg H, Herbst A, Kjellmer I, Lilja H, Lindoff C, M\u00e5nsson M, M\u00e5rtensson L, Olofsson P, Sundstr\u00f6m A, Mars\u00e1l K Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial. Lancet 2001;358:534-538"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 442,
            "data": {
                "is_heading": 0,
                "text": "Baskett TF, Arulkumaran S, 2002 Intrapartum Care for the MRCOG and Beyond. RCOG Press"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 443,
            "data": {
                "is_heading": 0,
                "text": "Bolten, M., & Chandraharan, E. (2019). The Significance of \u2018Non-Significant' Meconium Stained Amniotic Fluid (MSAF): Colour versus Contents. Journal of Advances in Medicine and Medical Research, 30(5), 1-7. https://doi.org/10.9734/jammr/2019/v30i530192"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 444,
            "data": {
                "is_heading": 0,
                "text": "Chandraharan E, Arulkumaran S. Prevention of birth asphyxia: responding appropriately to cardiotocograph (CTG) traces. Best Pract Res Clin Obstet Gynaecol. 2007 Aug;21(4):609-24."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 445,
            "data": {
                "is_heading": 0,
                "text": "Chandraharan E, Arulkumaran S. Intrapartum assessment of fetal health. Chapter. In: Current Obstetrics & Gynaecology. Mukhergee GM (ed). Jaypee Brothers, 2007. Chandraharan E, Arulkumaran S. Electronic Fetal Monitoring: Current and future practice. Review Article. Int J Obstet Gynaecol, 2008."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 446,
            "data": {
                "is_heading": 0,
                "text": "Chandraharan E. Fetal scalp blood sampling during labour: is it a useful diagnostic test or a historical test that no longer has a place in modern clinical obstetrics? BJOG. 2014 Aug;121(9):1056-60"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 447,
            "data": {
                "is_heading": 0,
                "text": "Chandraharan E. Foetal electrocardiograph (ST-analyser or STAN) for intrapartum foetal heart rate monitoring: a friend or a foe?. J Matern Fetal Neonatal Med. 2018;31(1):123-127. doi:10.1080/14767058.2016.1276559"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 448,
            "data": {
                "is_heading": 0,
                "text": "Eidelman AI, Nevet A, Rudensky B, Rabinowitz R, Hammerman C, Raveh D, Schimmel MS. The effect of meconium staining of amniotic fluid on the growth of Escherichia coli and group B streptococcus. J Perinatol. 2002;22(6):467-71."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 449,
            "data": {
                "is_heading": 0,
                "text": "FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. Ayres-de-Campos D, Spong CY, Chandraharan E; FIGO Intrapartum Fetal Monitoring Expert Consensus Panel. Int J Gynaecol Obstet. 2015 Oct;131(1):13-24"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 450,
            "data": {
                "is_heading": 0,
                "text": "Fitzpatrick T, Holt L (2008) \u2018A \u2018buddy' approach to CTG'. The Royal College of Midwives Journal, Oct/Nov: 40-4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 451,
            "data": {
                "is_heading": 0,
                "text": "Galli L, Dall'Asta A, Whelehan V, Archer A, Chandraharan E. Intrapartum cardiotocography patterns observed in suspected clinical and subclinical chorioamnionitis in term fetuses. J Obstet Gynaecol Res. 2019;45(12):2343-2350. doi:10.1111/jog.14133"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 452,
            "data": {
                "is_heading": 0,
                "text": "Ghi T, Chandraharan E, Fieni S, et al. Correlation between umbilical vein-to-artery delta pH and type of intrapartum hypoxia in a cohort of acidemic neonates: A retrospective analysis of CTG findings. Eur J Obstet Gynecol Reprod Biol. 2018;231:25-29. doi:10.1016/j.ejogrb.2018.10.005"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 453,
            "data": {
                "is_heading": 0,
                "text": "Gibb DMF, Arulkumaran S. 2008. Fetal Monitoring in Practice. 3rd Edition. .Churchill Livingstone Elsevier, London."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 454,
            "data": {
                "is_heading": 0,
                "text": "Gracia-Perez-Bonfils A, Vigneswaran K, Cuadras D, Chandraharan E. Does the saltatory pattern on cardiotocograph (CTG) trace really exist? The ZigZag pattern as an alternative definition and its correlation with perinatal outcomes [published online ahead of print, 2019 Nov 13]. J Matern Fetal Neonatal Med. 2019;1-9. doi:10.1080/14767058.2019.1686475"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 455,
            "data": {
                "is_heading": 0,
                "text": "Gracia-Perez-Bonfils A, Martinez-Perez O, Llurba E, Chandraharan E. Fetal heart rate changes on the cardiotocograph trace secondary to maternal COVID-19 infection [published online ahead of print, 2020 Jul 2]. Eur J Obstet Gynecol Reprod Biol. 2020;252:286-293. doi:10.1016/j.ejogrb.2020.06.049"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 456,
            "data": {
                "is_heading": 0,
                "text": "Jia YJ, Chen X, Cui HY, Whelehan V, Archer A, Chandraharan E. Physiological CTG interpretation: the significance of baseline fetal heart rate changes after the onset of decelerations and associated perinatal outcomes [published online ahead of print, 2019 Sep 18]. J Matern Fetal Neonatal Med. 2019;1-6. doi:10.1080/14767058.2019.1666819"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 457,
            "data": {
                "is_heading": 0,
                "text": "Luzietti R, Erkkola R, Hasbargen U, Mattsson LA, Thoulon JM, Ros\u00e9n KG European Community multi-Center Trial \"Fetal ECG Analysis During Labor\": ST plus CTG analysis. J Perinat Med 1999;27:431-440"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 458,
            "data": {
                "is_heading": 0,
                "text": "National Institute for Health and Clinical Excellence (NICE). (2004). Caesarean Section. London: NICE. Available at: www.nice.org.uk"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 459,
            "data": {
                "is_heading": 0,
                "text": "NICE Intrapartum Care Guidelines: care of healthy women and their babies in labour. September, 2007.nice.org.uk/nicemedia/pdf/IPCNICEGuidance.pdf"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 460,
            "data": {
                "is_heading": 0,
                "text": "National Health Service Litigation Authority. (2009). NHS Litigation Authority Study Of Stillbirth Claims. London: NHSLA. Available at: www.nhsla.com"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 461,
            "data": {
                "is_heading": 0,
                "text": "Nelson KB, Grether JK. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight. Am J Obstet Gynecol. 1998;179:507\u2013 513."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 462,
            "data": {
                "is_heading": 0,
                "text": "Nurani R, Chandraharan E, Lowe V, Ugwumadu A, Arulkumaran S. Misidentification of maternal heart rate as fetal on cardiotocography during the second stage of labor: the role of the fetal electrocardiograph. Acta Obstet Gynecol Scand. 2012 Aug 11."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 463,
            "data": {
                "is_heading": 0,
                "text": "Pereira S, Chandraharan E. Recognition of chronic hypoxia and pre-existing foetal injury on the cardiotocograph (CTG): Urgent need to think beyond the guidelines. Porto Biomed. 2017;4:124-9."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 464,
            "data": {
                "is_heading": 0,
                "text": "Pinas A, Chandraharan E. Continuous cardiotocography during labour: Analysis, classification and management. Best Pract Res Clin Obstet Gynaecol. 2016Jan;30:33-47."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 465,
            "data": {
                "is_heading": 0,
                "text": "Ros\u00e9n KG, Luzietti R The fetal electrocardiogram: ST waveform analysis during labour. J Perinat Med 1994;22:501-512"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 466,
            "data": {
                "is_heading": 0,
                "text": "Royal College of Anaesthetists, Royal College of Midwives, Royal College of Obstetricians and Gynaecologists, Royal College of Paediatrics and Child Health. (2007). Safer Childbirth: Minimum Standards For The Organisation And Delivery Of Care In Labour. London: RCOG Press. Available at: www.rcog.org.uk"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 467,
            "data": {
                "is_heading": 0,
                "text": "Royal College of Midwives. (2008). Midwifery Practice Guideline Fetal Heart Rate Monitoring. London: RCM. Available at: www.rcm.org.uk"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 468,
            "data": {
                "is_heading": 0,
                "text": "Royal College of Obstetricians & Gynaecologists. (2007). Birth After Previous Caesarean Section. London: RCOG. Available at: www.rcog.org.uk"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 469,
            "data": {
                "is_heading": 0,
                "text": "Symon A.G. et al (2006) \u2018An exploratory mixed-methods study of Scottish midwives' understandings and perceptions of clinical near misses in maternity care'. Midwifery, 22(2) : 125-136"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 470,
            "data": {
                "is_heading": 0,
                "text": "Ugwumadu A. Understanding cardiotocographic patterns associated with intrapartum fetal hypoxia and neurologic injury. Best Pract Res Clin Obstet Gynaecol. 2013 Aug;27(4):509-36."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 471,
            "data": {
                "is_heading": 0,
                "text": "Ugwumadu A. Are we (mis)guided by current guidelines on intrapartum fetalheart rate monitoring? Case for a more physiological approach to interpretation. BJOG. 2014 Aug;121(9):1063-70."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 472,
            "data": {
                "is_heading": 0,
                "text": "Vain N, Szyld E, Prudent L, Wiswell T, Aguilar A, vivas N Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicentre, randomized controlled trial. Lancet 2004;14, 364:597-602 Westgate J, Harris M, Curnow JS, Greene KR Randomised trial of cardiotocography alone or with ST waveform analysis for intrapartum monitoring. Lancet 1992;340:194-198"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 473,
            "data": {
                "is_heading": 0,
                "text": "Xie W, Archer A, Li C, Cui H, Chandraharan E. Fetal heart rate changes observed on the CTG trace during instrumental vaginal delivery. J Matern Fetal Neonatal Med. 2019;32(1):117-124. doi:10.1080/14767058.2017.1373084"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 474,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Checklist to exclude pre-existing hypoxia or injury"
            }
        },
        {
            "type": "image",
            "sequence_num": 475,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.015.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 476,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Hourly CTG assessment/ fresh eyes CTG sticker"
            }
        },
        {
            "type": "image",
            "sequence_num": 477,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.016.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 478,
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Fresh eyes sticker for \u201cintelligent\u201d intermittent auscultation"
            }
        },
        {
            "type": "image",
            "sequence_num": 479,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.017.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 480,
            "data": {
                "num_rows": 8,
                "num_cols": 8,
                "table_items": [
                    {
                        "text": "Ongoing assessment for fetal surveillance"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Any new risk factors identified? e.g Significant MSL, APH, prolonged 2nd stage, Maternal pyrexia, tachycardia or hypertension, RFM"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Abdominal palpation indicates abnormal SFH, presentation and uterine activity? e.g newly identified SGA , malpresentation, increased uterine tenderness or tone, fetal movements"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Baseline rate identified in abnormal range? <110bpm or >160bpm or increase in trend on the partogram? The fetal heart should be auscultated for 1 minute immediately following a contraction ever y 15 minutes in the first stage of labour and for 1 minute immediately following a contraction at least every 5 minutes in the suspected or confirmed second stage of labour. Maternal Pulse should be palpated to ensure differentiation."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Presence of decelerations? Gradual or abrupt fetal heart decreases below the BLR."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Absence of accelerations? Efforts should be made to auscultate the fetal heart during fetal movements to identify the presence of accelerations."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "IF YES transfer for continuous CTG monitoring and obstetric review should be arranged."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Plan:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 481,
            "data": {
                "is_heading": 1,
                "text": "Appendix 4: CTG features of chorioamnionitis"
            }
        },
        {
            "type": "image",
            "sequence_num": 482,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.019.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 483,
            "data": {
                "is_heading": 0,
                "text": "Galli L, Dall'Asta A, Whelehan V, Archer A, Chandraharan E. Intrapartum cardiotocography patterns observed in suspected clinical and subclinical chorioamnionitis in term fetuses. J Obstet Gynaecol Res. 2019;45(12):2343-2350. doi:10.1111/jog.14133"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 484,
            "data": {
                "is_heading": 1,
                "text": "Appendix 5: List of indications for continuous CTG monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 485,
            "data": {
                "is_heading": 0,
                "text": "Gestation <37 or > 42 weeks"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 486,
            "data": {
                "is_heading": 0,
                "text": "Previous caesarean section"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 487,
            "data": {
                "is_heading": 0,
                "text": "Ante/Intrapartum haemorrhage"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 488,
            "data": {
                "is_heading": 0,
                "text": "Induced labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 489,
            "data": {
                "is_heading": 0,
                "text": "Administration of oxytocin for induction/augmentation of labour Maternal illness (e.g. diabetes, cardiac, renal, thyroid disease) Pre-eclampsia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 490,
            "data": {
                "is_heading": 0,
                "text": "Severe hypertension: a single reading of either systolic blood pressure of 160 mmHg or more or diastolic blood pressure of 110 mmHg or more, measured between contractions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 491,
            "data": {
                "is_heading": 0,
                "text": "Hypertension: either systolic blood pressure of 140 mmHg or more or diastolic blood pressure of 90 mmHg or more on 2 consecutive readings taken 30 minutes apart, measured between contractions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 492,
            "data": {
                "is_heading": 0,
                "text": "A reading of 2+ of protein on urinalysis and a single reading of either raised systolic blood pressure (140 mmHg or more) or raised diastolic blood pressure (90 mmHg or more)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 493,
            "data": {
                "is_heading": 0,
                "text": "Abnormal Doppler artery velocimetry"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 494,
            "data": {
                "is_heading": 0,
                "text": "Known or suspected IUGR"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 495,
            "data": {
                "is_heading": 0,
                "text": "Two-vessel cord"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 496,
            "data": {
                "is_heading": 0,
                "text": "Oligohydramnios"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 497,
            "data": {
                "is_heading": 0,
                "text": "Breech presentation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 498,
            "data": {
                "is_heading": 0,
                "text": "Multiple pregnancy (all babies to be monitored) Meconium stained liquor"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 499,
            "data": {
                "is_heading": 0,
                "text": "Suspected chorioamnionitis or sepsis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 500,
            "data": {
                "is_heading": 0,
                "text": "Prolonged rupture of membranes* > 24 hours, if not already in established labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 501,
            "data": {
                "is_heading": 1,
                "text": "* In cases of prolonged rupture of membranes, the whole clinical picture should be considered and documented (ie. Indications of sepsis \u2013 maternal pyrexia, tachycardia, rise in fetal baseline heart rate, offensive smelling liquor, rigor, etc.) and a decision made as to the most appropriate form of fetal monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 502,
            "data": {
                "is_heading": 0,
                "prefix": 30.0,
                "text": "Maternal pulse over 120 beats/minute on 2 occasions  minutes apart Temperature of 38\u00b0C or above on a single reading, or 37.5\u00b0C or above on 2 consecutive occasions 1 hour apart"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 503,
            "data": {
                "is_heading": 0,
                "text": "Pain reported by the woman that differs from the pain normally associated with contractions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 504,
            "data": {
                "is_heading": 0,
                "text": "Confirmed delay in the first or second stage of labour Active pushing for over 1 hour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 505,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Contractions that last  mins or longer (hypertonus) or more than 5 contractions in 10 minutes (tachysystole)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 506,
            "data": {
                "is_heading": 0,
                "text": "Insertion of an epidural block and subsequent period Abnormal auscultation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 507,
            "data": {
                "is_heading": 0,
                "text": "Maternal request"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 508,
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "or more episodes of reduced fetal movements in the pregnancy requires CTG monitoring in labour"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 509,
            "data": {
                "is_heading": 1,
                "text": "Appendix 6: CTG classification to be used with STAN (applicable to Mid-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 510,
            "data": {
                "is_heading": 1,
                "text": "Essex once STAN is implemented)"
            }
        },
        {
            "type": "image",
            "sequence_num": 511,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.020.jpeg"
            }
        },
        {
            "type": "image",
            "sequence_num": 512,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.021.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 513,
            "data": {
                "is_heading": 0,
                "text": "Fetal monitoring in labour / MEHT-21011/1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 514,
            "data": {
                "is_heading": 1,
                "prefix": 52.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 515,
            "data": {
                "is_heading": 0,
                "text": "Fetal monitoring in labour / MEHT-21011/1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 516,
            "data": {
                "is_heading": 1,
                "text": "Appendix 7: Management algorithm for the use of STAN"
            }
        },
        {
            "type": "image",
            "sequence_num": 517,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.022.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 518,
            "data": {
                "is_heading": 1,
                "prefix": 49.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 519,
            "data": {
                "is_heading": 1,
                "text": "Appendix 8: Dawes Redman analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 520,
            "data": {
                "is_heading": 1,
                "text": "Pulse interval and baseline fetal heart rate: The time between two consecutive fetal heartbeats is called a pulse interval and is measured to accuracy of 1/1000th of a second"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 521,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "(=1 millisecond or ms). The pulse interval calculated in milliseconds is converted into fetal heart rate in beats per minute (bpm); as the fetal heart rate increases the pulse interval gets shorter and vice versa (If the heart rate is 120 bpm, then the heart beats every 0.5 sec or 500 ms; fetal heart rate in bpm = 60000/pulse interval in ms). The first thing the FetalCare does is to fit a baseline fetal heart rate to allow accelerations and decelerations to be identified and measured (baseline fitting algorithm is described elsewhere). All subsequent measurements are derived from this baseline fetal heart rate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 522,
            "data": {
                "is_heading": 1,
                "prefix": 60.0,
                "text": "Low & High FHR variation and cyclicity: The main emphasis in the analysis is placed on fetal heart rate variation. A primary function of the Oxford system is to detect episodes of low and high FHR variation. From about 28 weeks gestation onward, a healthy fetus cycles between episodes of active (associated with accelerations, high FHR variation, and clusters of fetal movements) and quiet sleep (associated with low FHR variation and reduced fetal movement). The low FHR variation of healthy fetuses during quiet sleep (which can last up to 50 minutes) cannot be distinguished from the low FHR variation of compromised fetuses. The minimum time taken for analysis is  minutes and the maximum duration of the computerised analysis of FHR is therefore  minutes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 523,
            "data": {
                "is_heading": 1,
                "text": "FHR Variation is measured in two ways \u2013 long term variation (LTV) and Short term variation (STV)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 524,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "LTV is a measure of the minute-by-minute \u2018macro' fluctuations of the fetal heart rate around the baseline. The minute range is the difference between the highest and the lowest fetal heart rate in each minute relative to the baseline (Figure ). The average of consecutive minute ranges is the mean minute range and this is used as a measure of LTV."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 525,
            "data": {
                "is_heading": 1,
                "text": "STV is a measure of the \u2018micro' fluctuations of the FHR and cannot be measured by eye. Fetal care measures STV by dividing each minute of the trace into 16 sections (3.75 seconds each). The average pulse interval in each section is calculated; the change in these average values from one section to the next determines the STV."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 526,
            "data": {
                "is_heading": 1,
                "text": "Once the baseline is fitted, any  accelerations or decelerations that are present are identified and measured. The size of a deceleration is computed from \u2018lost beats'."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 527,
            "data": {
                "is_heading": 1,
                "text": "STV is a very important parameter for two reasons."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 528,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "The importance of STV was established in two studies of compromised babies where traces were obtained within the 24 hours prior to intrauterine death (IUD) or delivery by caesarean section without labour. The outcomes for these pregnancies are summarised in Table   When  the  STV  was  less  than  2.6ms  there  was  a  dramatic  increase  in  the likelihood of metabolic acidaemia (as defined by an umbilical artery blood pH less than 7.12 and base deficit greater than 12mmol/L) or intrauterine death."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 529,
            "data": {
                "is_heading": 1,
                "text": "As the fetus deteriorates short term variation overall (STV) falls progressively. The STV trend analysis over a period of time may aid in deciding the optimum timing of delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 530,
            "data": {
                "is_heading": 1,
                "text": "STV (ms)    2.6-3.0  >3.0 Metabolic  10.3%  4.0%  2.7% acidaemia"
            }
        },
        {
            "type": "image",
            "sequence_num": 531,
            "data": {
                "url": "MEHT-21011 Fetal monitoring in labour guideline 1.0.023.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 532,
            "data": {
                "is_heading": 0,
                "text": "IUD  24.1%  4.3%  0.0%"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 533,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Measurement of Low and High FHR variation: An episode of low FHR variation is identified when the minute range in at least 5 of 6 consecutive 1-minute intervals is less than or equal to a threshold defined by a pulse interval of 30 ms. An episode of high fetal heart variation is provisionally identified when the minute range in at leastof 6 consecutive minutes is \u2265  ms. The mean minute range for the episode is then compared against a threshold (> st centile) calculated from the 73,802 traces in the FetalCare database. If it exceeds this threshold then the episode of high variation is confirmed and the trace is considered reactive. An episode of high variation indicates normality."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 534,
            "data": {
                "is_heading": 0,
                "text": "This definition of reactivity is unique in two respects: first, the threshold varies according to the gestational age of the fetus and second, it does not depend on the presence of accelerations, as these are not always present in traces from healthy fetuses. Other definitions of reactivity typically require two or more accelerations within a given time"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 535,
            "data": {
                "is_heading": 0,
                "text": "Fetal monitoring in labour / MEHT-21011/1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 536,
            "data": {
                "is_heading": 1,
                "prefix": 52.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 537,
            "data": {
                "is_heading": 0,
                "text": "Fetal monitoring in labour / MEHT-21011/1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 538,
            "data": {
                "is_heading": 1,
                "text": "Appendix 9: Preliminary equality analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 539,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Fetal monitoring in labour/MEHT-21011 (please tick all that apply)"
            }
        },
        {
            "type": "table",
            "sequence_num": 540,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing policy"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new policy"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 541,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "The guideline for the use and interpretation of fetal monitoring"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To ensure practice is evidence based"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Babies and families in our care"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Please see page 1& 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 542,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Katharine Reeves"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Fetal Surveillance Midwife"
                    },
                    {
                        "text": "20 April 2021"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 543,
            "data": {
                "is_heading": 1,
                "prefix": 49.0,
                "text": "Page  of"
            }
        }
    ]
}